Updates on health agency nominees; New data from Pfizer, Beam; MASH startup weighs IPO; and morenews2025-03-15T10:00:55+00:00March 15th, 2025|Endpoints News|
Dr. Oz says he would defend Medicare drug price negotiationsnews2025-03-14T19:07:18+00:00March 14th, 2025|Endpoints News|
Federal Circuit ruling keeps Amgen’s Eylea biosimilar on the marketnews2025-03-14T19:05:53+00:00March 14th, 2025|Endpoints News|
Boston Pharma mulls IPO amid MASH momentumnews2025-03-14T19:00:00+00:00March 14th, 2025|Endpoints News|
UK’s drugmaker rebate plan draws scrutiny from industrynews2025-03-14T17:47:32+00:00March 14th, 2025|Endpoints News|
Recipharm hits record revenue, eyes GLP-1 deals for growth news2025-03-14T17:07:23+00:00March 14th, 2025|Endpoints News|
RFK Jr. convened roundtable around ways to reduce stem cell regulationnews2025-03-14T15:36:02+00:00March 14th, 2025|Endpoints News|
Altimmune to put its incretin into addiction trials; Tarsus aims to raise $125Mnews2025-03-14T15:17:18+00:00March 14th, 2025|Endpoints News|
Sutro slashes workforce in half, changes CEO and closes factorynews2025-03-14T12:32:54+00:00March 14th, 2025|Endpoints News|
Merck diversity leader to retire this summer; Geron seeks commercial chops for next CEOnews2025-03-14T11:00:39+00:00March 14th, 2025|Endpoints News|
